Our findings demonstrated that AA pretreatment efficiently restored damage of the hepatic architecture and reduced TNF-α, IL-6, and IL-1β secretion in mice with L/D-induced FHF. The gene discussed is IL1B; the disease is TNF receptor 1-associated periodic fever syndrome.